<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="364520">
  <stage>Registered</stage>
  <submitdate>28/06/2013</submitdate>
  <approvaldate>2/07/2013</approvaldate>
  <actrnumber>ACTRN12613000734763</actrnumber>
  <trial_identification>
    <studytitle>O'Mega Man Study: an investigation of fish oil and micronutrient supplementation on aggressive behaviour in a sample of inmates in a NSW Correctional Centre</studytitle>
    <scientifictitle>Effect of fish oil and micronutrient supplementation on aggressive behaviour of adult offenders: a Randomised Control Trial (RCT) pilot and feasibility study</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Mental Health</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Other mental health disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Tuna Oil capsules ( 3 x 1g capsules per day for 16 weeks) AND
Multi-vitamins and minerals (1 tablet per day for 16 weeks) The multi-vitamins tablet contains the following:
Vitamin A (as retinyl palmitate)	750 IU
Thiamin hydrochloride (vitamin B1)	50mg
Riboflavin (vitamin B2)	20mg
Nicotinic acid (vitamin B3)	10mg
Nicotinamide (vitamin B3)	200mg
Pantothenic acid (as calcium salt) (vitamin B5)	100mg
Pyridoxine hydrochloride (vitamin B6)	50mg
Cyanocobalamin (vitamin B12)	100mcg
Ascorbic acid (vitamin C)	50mg
Vitamin D3 (cholecalciferol)	100 IU
Vitamin E (as d-alpha tocopherol acid succinate)	25 IU
Betacarotene	3mg
Biotin	20mcg
Folic Acid (vitamin B9)	150mcg
Calcium (as amino acid chelate)	10mg
Cobalt (as chloride)	25mcg
Copper (as amino acid chelate)	6mcg
Lithium (as carbonate)	140mcg
Magnesium (as L-aspartate and phosphate)	7.6mg
Manganese (as sulphate)	93mcg
Potassium (as L-aspartate)	2mg
Potassium (as di-hydrogen phosphate)	13.6mg
Zinc (as gluconate)	1.3mg
Zinc (as sulphate)	7.6mg
Amino-benzoic acid	20mg
Choline bi-tartrate	50mg
Inositol	25mg
Scutellaria lateriflora (Equiv. dry herb)	100mg
Valeriana officinalis (Equiv. dry root)	100mg
L-Glutamine	50mg
Lysine hydrochloride	10mg
Betaine hydrochloride	10mg

Administered simultaneously
One week supply will be provided in a blister pack and the empty blister pack is returned prior to receiving the next week's supply</interventions>
    <comparator>Sunola Oil capsules (3 x 1g capsules per day for 16 weeks) AND  Multi-vitamins and minerals (1 tablet per day for 16 weeks) The multi-vitamins tablet contains the following: Vitamin A (as retinyl palmitate) 750 IU Thiamin hydrochloride (vitamin B1) 50mg Riboflavin (vitamin B2) 20mg Nicotinic acid (vitamin B3) 10mg Nicotinamide (vitamin B3) 200mg Pantothenic acid (as calcium salt) (vitamin B5) 100mg Pyridoxine hydrochloride (vitamin B6) 50mg Cyanocobalamin (vitamin B12) 100mcg Ascorbic acid (vitamin C) 50mg Vitamin D3 (cholecalciferol) 100 IU Vitamin E (as d-alpha tocopherol acid succinate) 25 IU Betacarotene 3mg Biotin 20mcg Folic Acid (vitamin B9) 150mcg Calcium (as amino acid chelate) 10mg Cobalt (as chloride) 25mcg Copper (as amino acid chelate) 6mcg Lithium (as carbonate) 140mcg Magnesium (as L-aspartate and phosphate) 7.6mg Manganese (as sulphate) 93mcg Potassium (as L-aspartate) 2mg Potassium (as di-hydrogen phosphate) 13.6mg Zinc (as gluconate) 1.3mg Zinc (as sulphate) 7.6mg Amino-benzoic acid 20mg Choline bi-tartrate 50mg Inositol 25mg Scutellaria lateriflora (Equiv. dry herb) 100mg Valeriana officinalis (Equiv. dry root) 100mg L-Glutamine 50mg Lysine hydrochloride 10mg Betaine hydrochloride 10mg Administered simultaneously. One week supply will be provided in a blister pack and the empty blister pack is returned prior to receiving the next week's supply </comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Other</interventioncode>
    <interventioncode>Behaviour</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Aggressive Behaviour will be assessed by the number of reports recorded in the Correctional Centre AND a rating system of behaviour will be applied to the individual study participants case notes</outcome>
      <timepoint>at baseline and 4 months after randomisation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Aggressive cognitions will be assessed by the Aggression Questionnaire</outcome>
      <timepoint>at baseline and 4 months after randomisation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Attention Deficit Disorder will be assessed using the Brown's Attention Deficit Disorder</outcome>
      <timepoint>at baseline and 4 months after randomisation</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Resident of South Coast Correctional Centre and minimum stay of 4 months</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Males</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Erythrocyte EPA and DHA of greater than 6% of total fatty acids</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>True</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>28/06/2013</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>200</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Barbara Meyer</primarysponsorname>
    <primarysponsoraddress>School of Medicine and Health
University of Wollongong
Northfields Ave
Wollongong 
NSW 2522</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of Wollongong</fundingname>
      <fundingaddress>Northfields Ave 
Wollongong
NSW 2522</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Department of Corrective Services, NSW</fundingname>
      <fundingaddress>GPO Box 31, Sydney NSW 2001</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Nu Mega Ingredients
In kind support of fish oil and sunola oil capsules</fundingname>
      <fundingaddress>31 PINNACLE ROAD, ALTONA NORTH, 3025, VICTORIA, AUSTRALIA</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Nutrition Care Pharmaceuticals Pty Ltd
In kind support of the multi-vitamins and minerals</fundingname>
      <fundingaddress>25 - 31 Keysborough Avenue
Keysborough, Victoria 3173, Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary purpose of this study is to assess the feasibility of conducting a placebo controlled trial in the Corrective Services setting and also to generate pilot data for use in the application of funding for a multi-centre trial in due course.
It is expected that the fish oil plus micronutrients supplemented group will have reduced aggressive behaviour comapred to the placebo group.
</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Barbara Meyer</name>
      <address>School of Medicine and Health
University of Wollongong
Northfields Ave
Wollongong NSW 2522</address>
      <phone>+61 2 4221 3459</phone>
      <fax />
      <email>bmeyer@uow.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Barbara Meyer</name>
      <address>School of Medicine and Health
University of Wollongong
Northfields Ave
Wollongong NSW 2522</address>
      <phone>+61 2 4221 3459</phone>
      <fax />
      <email>bmeyer@uow.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Barbara Meyer</name>
      <address>School of Medicine and Health
University of Wollongong
Northfields Ave
Wollongong NSW 2522</address>
      <phone>+61 2 4221 3459</phone>
      <fax />
      <email>bmeyer@uow.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Barbara Meyer</name>
      <address>School of Medicine and Health
University of Wollongong
Northfields Ave
Wollongong NSW 2522</address>
      <phone>+61 2 4221 3459</phone>
      <fax />
      <email>bmeyer@uow.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>